Free Trial

Cresco Labs (OTCMKTS:CRLBF) Releases Earnings Results, Meets Estimates

Cresco Labs logo with Medical background
Remove Ads

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) issued its quarterly earnings results on Friday. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01), Zacks reports. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. The company had revenue of $176.00 million for the quarter, compared to analysts' expectations of $172.10 million.

Cresco Labs Trading Up 1.4 %

OTCMKTS CRLBF traded up $0.01 on Wednesday, hitting $0.72. 2,218,801 shares of the company were exchanged, compared to its average volume of 621,663. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.97 and a quick ratio of 1.39. Cresco Labs has a twelve month low of $0.70 and a twelve month high of $2.60. The firm has a market capitalization of $349.02 million, a P/E ratio of -3.58 and a beta of 1.79. The company's 50 day moving average price is $0.88 and its 200-day moving average price is $1.19.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Cormark upgraded shares of Cresco Labs from a "hold" rating to a "moderate buy" rating in a research report on Monday. Atb Cap Markets downgraded shares of Cresco Labs from a "strong-buy" rating to a "hold" rating in a report on Monday, December 9th. Two analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Cresco Labs currently has an average rating of "Buy" and an average price target of $3.00.

Remove Ads

Check Out Our Latest Stock Report on Cresco Labs

Cresco Labs Company Profile

(Get Free Report)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Read More

Earnings History for Cresco Labs (OTCMKTS:CRLBF)

Should You Invest $1,000 in Cresco Labs Right Now?

Before you consider Cresco Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.

While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Is Marjorie Taylor Greene the next Nancy Pelosi when it comes to stock trading? After being appointed to the DOGE Committee, MTG made a significant Tesla stock purchase—raising questions about congres

Related Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads